Icon

SESQUIENT (nda210864)- (EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML),EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML))

FOSPHENYTOIN SODIUM LUPIN
EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML),EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML)
No Yes
2033-Feb-27 Expired
None None
None No
SESQUIENT is indicated: • for the treatment of generalized tonic-clonic status epilepticus in adult patients • prevention and treatment of seizures occurring during neurosurgery in adult patients • for short-term substitution for oral phenytoin in patients 2 years of age and older. SESQUIENT should be used only when oral phenytoin administration is not possible.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) ** ** - - -
EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.